A Clinical Trial of Immunosuppressive Therapy for Myocarditis
Jay W. Mason, M.D., John B. O'Connell, M.D., Ahvie Herskowitz, M.D., Noel R. Rose, M.D., Ph.D., Bruce M. McManus, M.D., Ph.D., Margaret E. Billingham, M.D., Thomas E. Moon, Ph.D., for The Myocarditis Treatment Trial Investigators
Background Myocarditis is a serious disorder, and treatmentoptions are limited. This trial was designed to determine whetherimmunosuppressive therapy improves left ventricular functionin patients with myocarditis.
Methods We randomly assigned 111 patients with a histopathologicaldiagnosis of myocarditis and a left ventricular ejection fractionof less than 0.45 to receive conventional therapy alone or combinedwith a 24-week regimen of immunosuppressive therapy. Immunosuppressivetherapy consisted of prednisone with either cyclosporine orazathioprine. The primary outcome measure was a change in theleft ventricular ejection fraction at 28 weeks.
Results In the group as a whole, the mean (±SE) leftventricular ejection fraction improved from 0.25±0.01at base line to 0.34±0.02 at 28 weeks (P<0.001). Themean change in the left ventricular ejection fraction at 28weeks did not differ significantly between the group of patientswho received immunosuppressive therapy (a gain of 0.10; 95 percentconfidence interval, 0.07 to 0.12) and the control group (again of 0.07; 95 percent confidence interval, 0.03 to 0.12).A higher left ventricular ejection fraction at base line, lessintensive conventional drug therapy at base line, and a shorterduration of disease, but not the treatment assignment, werepositive independent predictors of the left ventricular ejectionfraction at week 28. There was no significant difference insurvival between the two groups (P = 0.96). The mortality ratefor the entire group was 20 percent at 1 year and 56 percentat 4.3 years. Features suggesting an effective inflammatoryresponse were associated with less severe initial disease.
Conclusions Our results do not support routine treatment ofmyocarditis with immunosuppressive drugs. Ventricular functionimproved regardless of whether patients received immunosuppressivetherapy, but long-term mortality was high.
Source Information
From the Division of Cardiology, University of Utah, Salt Lake City (J.W.M.); the Department of Medicine, University of Mississippi, Jackson (J.B.O.); the Division of Cardiology (A.H.) and the Department of Molecular Microbiology and Immunology (N.R.R.), Johns Hopkins University, Baltimore; the Department of Pathology, University of British Columbia, Vancouver (B.M.M.); the Department of Pathology, Stanford University, Stanford, Calif. (M.E.B.); and the Department of Family and Community Medicine, University of Arizona, Tucson (T.E.M.).
Address reprint requests to Dr. Mason at the Cardiology Division, University of Utah Medical Center, 50 N. Medical Dr., Salt Lake City, UT 84132.
Cyclosporine and Methotrexate for Severe Rheumatoid Arthritis
Schlesinger N., Huppert A., Hoch S., Malleson P., Steinberg A. D., Rosh J. R., Birnbaum A. H., van de Rijn M., Kamel O. W., Storb R., Thomas E. D., Tugwell P., Yocum D., Pincus T., Wells G.
Extract |
Full Text
N Engl J Med 1995;
333:1567-1569, Dec 7, 1995.
Correspondence
Immunosuppressive Therapy for Myocarditis
Cunnion R. E., Parrillo J. E., Maisch B., Camerini F., Schultheiss H.-P., Cooper L. T., Shabetai R., Mason J. W., O'Connell J. B., McManus B. M.
Extract |
Full Text
N Engl J Med 1995;
333:1713-1714, Dec 21, 1995.
Correspondence
This article has been cited by other articles:
Fayssoil, A., Nardi, O., Orlikowski, D., Combes, A., Chastre, J., Annane, D.
(2010). Percutaneous Extracorporeal Membrane Oxygenation for Cardiogenic Shock Due to Acute Fulminant Myocarditis.. Ann. Thorac. Surg.
89: 614-616
[Abstract][Full Text]
Cocker, M S, Abdel-Aty, H, Strohm, O, Friedrich, M G
(2009). Age and gender effects on the extent of myocardial involvement in acute myocarditis: a cardiovascular magnetic resonance study. Heart
95: 1925-1930
[Abstract][Full Text]
Schultz, J. C., Hilliard, A. A., Cooper, L. T. Jr, Rihal, C. S.
(2009). Diagnosis and Treatment of Viral Myocarditis. Mayo Clin Proc.
84: 1001-1009
[Abstract][Full Text]
Frustaci, A., Russo, M. A., Chimenti, C.
(2009). Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. Eur Heart J
30: 1995-2002
[Abstract][Full Text]
Cooper, L. T.
(2009). The heat is off: immunosuppression for myocarditis revisited. Eur Heart J
30: 1936-1939
[Full Text]
Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol
53: e1-e90
[Full Text]
2005 WRITING COMMITTEE MEMBERS, , Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., Michl, K., Oates, J. A., Rahko, P. S., Silver, M. A., Stevenson, L. W., Yancy, C. W.
(2009). 2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in Collaboration With the International Society for Heart and Lung Transplantation. Circulation
119: e391-e479
[Full Text]
Cooper, L. T. Jr.
(2009). Myocarditis. NEJM
360: 1526-1538
[Full Text]
Yuan, J., Liu, Z., Lim, T., Zhang, H., He, J., Walker, E., Shier, C., Wang, Y., Su, Y., Sall, A., McManus, B., Yang, D.
(2009). CXCL10 Inhibits Viral Replication Through Recruitment of Natural Killer Cells in Coxsackievirus B3-Induced Myocarditis. Circ. Res.
104: 628-638
[Abstract][Full Text]
Calvin, A. D., Geske, J. B., Bell, M. R.
(2008). 69-Year-Old Woman With Rapid Heartbeat. Mayo Clin Proc.
83: 1392-1395
[Full Text]
Tunca, R., Sozmen, M., Erdogan, H., Citil, M., Uzlu, E., Ozen, H., Gokce, E.
(2008). Determination of cardiac troponin I in the blood and heart of calves with foot-and-mouth disease. jvdi
20: 598-605
[Abstract][Full Text]
Dennert, R., Crijns, H. J., Heymans, S.
(2008). Acute viral myocarditis. Eur Heart J
29: 2073-2082
[Abstract][Full Text]
Kindermann, I., Kindermann, M., Kandolf, R., Klingel, K., Bultmann, B., Muller, T., Lindinger, A., Bohm, M.
(2008). Predictors of Outcome in Patients With Suspected Myocarditis. Circulation
118: 639-648
[Abstract][Full Text]
Shijie, Z., Moriya, J., Yamakawa, J., Chen, R., Takahashi, T., Sumino, H., Nakahashi, T., Iwai, K., Morimoto, S., Yamaguchi, N., Kanda, T.
(2008). Mao-to Prolongs the Survival of and Reduces TNF-{alpha} Expression in Mice with Viral Myocarditis. Evid Based Complement Alternat Med
0: nen010v1-nen010
[Abstract][Full Text]
Brunetti, L., DeSantis, E. R. H.
(2008). Treatment of viral myocarditis caused by coxsackievirus B. Am J Health Syst Pharm
65: 132-137
[Abstract][Full Text]
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R.
(2007). The role of endomyocardial biopsy in the management of cardiovascular disease: A Scientific Statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. Eur Heart J
28: 3076-3093
[Full Text]
Freedman, S. B., Haladyn, J. K., Floh, A., Kirsh, J. A., Taylor, G., Thull-Freedman, J.
(2007). Pediatric Myocarditis: Emergency Department Clinical Findings and Diagnostic Evaluation. Pediatrics
120: 1278-1285
[Abstract][Full Text]
Sechtem, U, Mahrholdt, H, Vogelsberg, H
(2007). Cardiac magnetic resonance in myocardial disease. Heart
93: 1520-1527
[Abstract][Full Text]
Sabatine, M. S., Poh, K.-K., Mega, J. L., Shepard, J.-A. O., Stone, J. R., Frosch, M. P.
(2007). Case 36-2007 -- A 31-Year-Old Woman with Rash, Fever, and Hypotension. NEJM
357: 2167-2178
[Full Text]
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R.
(2007). The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol
50: 1914-1931
[Full Text]
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., Virmani, R., Endorsed by the Heart Failure Society of America a,
(2007). The Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease: A Scientific Statement From the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation
116: 2216-2233
[Full Text]
Chen, E. F., Paterick, T. E.
(2007). 20-Year-Old Man With Chest Pain and Malaise. Mayo Clin Proc.
82: 1124-1127
[Full Text]
Caforio, A. L.P., Calabrese, F., Angelini, A., Tona, F., Vinci, A., Bottaro, S., Ramondo, A., Carturan, E., Iliceto, S., Thiene, G., Daliento, L.
(2007). A prospective study of biopsy-proven myocarditis: prognostic relevance of clinical and aetiopathogenetic features at diagnosis. Eur Heart J
28: 1326-1333
[Abstract][Full Text]
Daubeney, P. E. F., Nugent, A. W., Chondros, P., Carlin, J. B., Colan, S. D., Cheung, M., Davis, A. M., Chow, C.W., Weintraub, R. G., on behalf of the National Australian Childhood Car,
(2006). Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study. Circulation
114: 2671-2678
[Abstract][Full Text]
Developed in Collaboration With the European Heart, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B., Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L.
(2006). ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death). J Am Coll Cardiol
48: e247-e346
[Full Text]
Writing Committee Members, , Zipes, D. P., Camm, A. J., Borggrefe, M., Buxton, A. E., Chaitman, B., Fromer, M., Gregoratos, G., Klein, G., Moss, A. J., Myerburg, R. J., Priori, S. G., Quinones, M. A., Roden, D. M., Silka, M. J., Tracy, C., ESC Committee for Practice Guidelines, , Priori, S. G., Blanc, J.-J., Budaj, A., Camm, A. J., Dean, V., Deckers, J. W., Despres, C., Dickstein, K., Lekakis, J., McGregor, K., Metra, M., Morais, J., Osterspey, A., Tamargo, J. L., Zamorano, J. L., ACC/AHA Task Force Members, , Smith, S. C. Jr, Jacobs, A. K., Adams, C. D., Antman, E. M., Anderson, J. L., Hunt, S. A., Halperin, J. L., Nishimura, R., Ornato, J. P., Page, R. L., Riegel, B.
(2006). ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Europace
8: 746-837
[Full Text]
Esfandiarei, M., Suarez, A., Amaral, A., Si, X., Rahmani, M., Dedhar, S., McManus, B. M.
(2006). Novel Role for Integrin-Linked Kinase in Modulation of Coxsackievirus B3 Replication and Virus-Induced Cardiomyocyte Injury. Circ. Res.
99: 354-361
[Abstract][Full Text]
Da Silva, J A P, Jacobs, J W G, Kirwan, J R, Boers, M, Saag, K G, Ines, L B S, de Koning, E J P, Buttgereit, F, Cutolo, M, Capell, H, Rau, R, Bijlsma, J W J
(2006). Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data. Ann Rheum Dis
65: 285-293
[Abstract][Full Text]
Rutschow, S., Li, J., Schultheiss, H.-P., Pauschinger, M.
(2006). Myocardial proteases and matrix remodeling in inflammatory heart disease. Cardiovasc Res
69: 646-656
[Abstract][Full Text]
Magnani, J. W., Dec, G. W.
(2006). Myocarditis: Current Trends in Diagnosis and Treatment. Circulation
113: 876-890
[Full Text]
Allanore, Y, Vignaux, O, Arnaud, L, Puechal, X, Pavy, S, Duboc, D, Legmann, P, Kahan, A
(2006). Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis
65: 249-252
[Abstract][Full Text]
Cooper, L. T., Virmani, R., Chapman, N. M., Frustaci, A., Rodeheffer, R. J., Cunningham, M. W., McNamara, D. M.
(2006). National Institutes of Health-Sponsored Workshop on Inflammation and Immunity in Dilated Cardiomyopathy. Mayo Clin Proc.
81: 199-204
[Abstract][Full Text]
Baughman, K. L.
(2006). Diagnosis of Myocarditis: Death of Dallas Criteria. Circulation
113: 593-595
[Full Text]
Goser, S., Ottl;, R., Brodner, A., Dengler, T. J., Torzewski, J., Egashira, K., Rose, N. R., Katus, H. A., Kaya, Z.
(2005). Critical Role for Monocyte Chemoattractant Protein-1 and Macrophage Inflammatory Protein-1{alpha} in Induction of Experimental Autoimmune Myocarditis and Effective Anti-Monocyte Chemoattractant Protein-1 Gene Therapy. Circulation
112: 3400-3407
[Abstract][Full Text]
Asaumi, Y., Yasuda, S., Morii, I., Kakuchi, H., Otsuka, Y., Kawamura, A., Sasako, Y., Nakatani, T., Nonogi, H., Miyazaki, S.
(2005). Favourable clinical outcome in patients with cardiogenic shock due to fulminant myocarditis supported by percutaneous extracorporeal membrane oxygenation. Eur Heart J
26: 2185-2192
[Abstract][Full Text]
Sheppard, R., Bedi, M., Kubota, T., Semigran, M. J., Dec, W., Holubkov, R., Feldman, A. M., Rosenblum, W. D., McTiernan, C. F., McNamara, D. M., for the IMAC Investigators,
(2005). Myocardial Expression of Fas and Recovery of Left Ventricular Function in Patients With Recent-Onset Cardiomyopathy. J Am Coll Cardiol
46: 1036-1042
[Abstract][Full Text]
Mann, D. L.
(2005). Determinants of Myocardial Recovery in Myocarditis: Has the Time Come for Molecular Fingerprinting?. J Am Coll Cardiol
46: 1043-1044
[Full Text]
Si, X., McManus, B. M., Zhang, J., Yuan, J., Cheung, C., Esfandiarei, M., Suarez, A., Morgan, A., Luo, H.
(2005). Pyrrolidine Dithiocarbamate Reduces Coxsackievirus B3 Replication through Inhibition of the Ubiquitin-Proteasome Pathway. J. Virol.
79: 8014-8023
[Abstract][Full Text]
Abdel-Aty, H., Boye, P., Zagrosek, A., Wassmuth, R., Kumar, A., Messroghli, D., Bock, P., Dietz, R., Friedrich, M. G., Schulz-Menger, J.
(2005). Diagnostic Performance of Cardiovascular Magnetic Resonance in Patients With Suspected Acute Myocarditis: Comparison of Different Approaches. J Am Coll Cardiol
45: 1815-1822
[Abstract][Full Text]
Leeper, N. J., Wener, L. S., Dhaliwal, G., Saint, S., Wachter, R. M.
(2005). One Surprise after Another. NEJM
352: 1474-1479
[Full Text]
Maisch, B.
(2005). Recurrent pericarditis: mysterious or not so mysterious?. Eur Heart J
26: 631-633
[Full Text]
Matsumori, A.
(2005). Hepatitis C Virus Infection and Cardiomyopathies. Circ. Res.
96: 144-147
[Full Text]
Pieroni, M., Chimenti, C., Frustaci, A., Nanthakumar, K., Lau, Y. R., Plumb, V. J., Epstein, A. E., Kay, G. N.
(2005). Letter Regarding Article by Nanthakumar et al, "Electrophysiological Findings in Adolescents With Atrial Fibrillation Who Have Structurally Normal Hearts" * Response. Circulation
111: e27-e27
[Full Text]
Fuse, K., Kodama, M., Okura, Y., Ito, M., Kato, K., Hanawa, H., Aizawa, Y.
(2005). Short-term prognostic value of initial serum levels of interleukin-10 in patients with acute myocarditis. Eur J Heart Fail
7: 109-112
[Abstract][Full Text]
Grinda, J.-M., Chevalier, P., D'Attellis, N., Bricourt, M.-O., Berrebi, A., Guibourt, P., Fabiani, J.-N., Deloche, A.
(2004). Fulminant myocarditis in adults and children: bi-ventricular assist device for recovery. Eur. J. Cardiothorac. Surg.
26: 1169-1173
[Abstract][Full Text]
Shioji, K., Yuan, Z., Kita, T., Kishimoto, C.
(2004). Immunoglobulin treatment suppressed adoptively transferred autoimmune myocarditis in severe combined immunodeficient mice. Am. J. Physiol. Heart Circ. Physiol.
287: H2619-H2625
[Abstract][Full Text]
Shen, Y., Xu, W., Chu, Y.-W., Wang, Y., Liu, Q.-S., Xiong, S.-D.
(2004). Coxsackievirus Group B Type 3 Infection Upregulates Expression of Monocyte Chemoattractant Protein 1 in Cardiac Myocytes, Which Leads to Enhanced Migration of Mononuclear Cells in Viral Myocarditis. J. Virol.
78: 12548-12556
[Abstract][Full Text]
Burch, M
(2004). Immune suppressive treatment in paediatric myocarditis: still awaiting the evidence. Heart
90: 1103-1104
[Full Text]
Gagliardi, M G., Bevilacqua, M, Bassano, C, Leonardi, B, Boldrini, R, Camassei, F D., Fierabracci, A, Ugazio, A G, Bottazzo, G F
(2004). Long term follow up of children with myocarditis treated by immunosuppression and of children with dilated cardiomyopathy. Heart
90: 1167-1171
[Abstract][Full Text]
Knowlton, K. U., Yajima, T.
(2004). Interleukin-10: Biomarker or pathologic cytokine in fulminant myocarditis?. J Am Coll Cardiol
44: 1298-1300
[Full Text]
Peker, C., Sarda-Mantel, L., Loiseau, P., Rouzet, F., Nazneen, L., Martet, G., Vrigneaud, J.-M., Meulemans, A., Saumon, G., Michel, J.-B., Le Guludec, D.
(2004). Imaging Apoptosis with 99mTc-Annexin-V in Experimental Subacute Myocarditis. JNM
45: 1081-1086
[Abstract][Full Text]
Hia, C P P, Yip, W C L, Tai, B C, Quek, S C
(2004). Immunosuppressive therapy in acute myocarditis: an 18 year systematic review. Arch. Dis. Child.
89: 580-584
[Abstract][Full Text]
Cassimatis, D. C., Atwood, J. E., Engler, R. M., Linz, P. E., Grabenstein, J. D., Vernalis, M. N.
(2004). Smallpox vaccination and myopericarditis: a clinical review. J Am Coll Cardiol
43: 1503-1510
[Abstract][Full Text]
Esfandiarei, M., Luo, H., Yanagawa, B., Suarez, A., Dabiri, D., Zhang, J., McManus, B. M.
(2004). Protein Kinase B/Akt Regulates Coxsackievirus B3 Replication through a Mechanism Which Is Not Caspase Dependent. J. Virol.
78: 4289-4298
[Abstract][Full Text]
Taylor, J. A., Havari, E., McInerney, M. F., Bronson, R., Wucherpfennig, K. W., Lipes, M. A.
(2004). A Spontaneous Model for Autoimmune Myocarditis Using the Human MHC Molecule HLA-DQ8. J. Immunol.
172: 2651-2658
[Abstract][Full Text]
Mason, J. W
(2003). Myocarditis and dilated cardiomyopathy: An inflammatory link. Cardiovasc Res
60: 5-10
[Abstract][Full Text]
Calabrese, F., Thiene, G.
(2003). Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res
60: 11-25
[Abstract][Full Text]
Li, S. S.-l., Cheng, C.-w., Fu, C.-l., Chan, Y.-h., Lee, M.-p., Chan, J. W.-m., Yiu, S.-f.
(2003). Left Ventricular Performance in Patients With Severe Acute Respiratory Syndrome: A 30-Day Echocardiographic Follow-Up Study. Circulation
108: 1798-1803
[Abstract][Full Text]
Leprince, P., Combes, A., Bonnet, N., Ouattara, A., Luyt, C. E., Theodore, P., Leger, P., Pavie, A.
(2003). Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur. J. Cardiothorac. Surg.
24: 399-403
[Abstract][Full Text]
Noutsias, M., Pauschinger, M., Schultheiss, H.-P., Kuhl, U.
(2003). Cytotoxic perforin+ and TIA-1+ infiltrates are associated with cell adhesion molecule expression in dilated cardiomyopathy. Eur J Heart Fail
5: 469-479
[Abstract][Full Text]
Futamatsu, H., Suzuki, J.-i., Kosuge, H., Yokoseki, O., Kamada, M., Ito, H., Inobe, M., Isobe, M., Uede, T.
(2003). Attenuation of experimental autoimmune myocarditis by blocking activated T cells through inducible costimulatory molecule pathway. Cardiovasc Res
59: 95-104
[Abstract][Full Text]
Nugent, A. W., Daubeney, P. E.F., Chondros, P., Carlin, J. B., Cheung, M., Wilkinson, L. C., Davis, A. M., Kahler, S. G., Chow, C.W., Wilkinson, J. L., Weintraub, R. G., the National Australian Childhood Cardiomyopathy S,
(2003). The Epidemiology of Childhood Cardiomyopathy in Australia. NEJM
348: 1639-1646
[Abstract][Full Text]
Frustaci, A., Chimenti, C., Calabrese, F., Pieroni, M., Thiene, G., Maseri, A.
(2003). Immunosuppressive Therapy for Active Lymphocytic Myocarditis: Virological and Immunologic Profile of Responders Versus Nonresponders. Circulation
107: 857-863
[Abstract][Full Text]
Liu, P., Lee, P., Fuse, K., Nian, M.
(2002). Molecular pathophysiological mechanisms in virus infected host myocardium. Eur Heart J Suppl
4: I37-I41
[Abstract]
Noutsias, M., Pauschinger, M., Schultheiss, H.-P., Kuhl, U.
(2002). Advances in the immunohistological diagnosis of inflammatory cardiomyopathy. Eur Heart J Suppl
4: I54-I62
[Abstract]
Felix, S.B., Staudt, A., Baumann, G.
(2002). Immunoadsorption as a new therapeutic principle for treatment of dilated cardiomyopathy. Eur Heart J Suppl
4: I63-I68
[Abstract]
Frustaci, A., Pieroni, M., Chimenti, C.
(2002). Immunosuppressive therapy in inflammatory cardiomyopathy. Eur Heart J Suppl
4: I69-I72
[Abstract]
Kuhl, U., Pauschinger, M., Noutsias, M., Kapp, J.-F., Schultheiss, H.-P.
(2002). Diagnosis and treatment of patients with virus induced inflammatory cardiomyopathy. Eur Heart J Suppl
4: I73-I80
[Abstract]
Hjalmarson, A., Fu, M., Mobini, R.
(2002). Who are the enemies? Inflammation and autoimmune mechanisms. Eur Heart J Suppl
4: G27-G32
[Abstract]
Frustaci, A., Calabrese, F., Chimenti, C., Pieroni, M., Thiene, G., Maseri, A.
(2002). Lone Hepatitis C Virus Myocarditis Responsive to Immunosuppressive Therapy. Chest
122: 1348-1356
[Abstract][Full Text]
Burch, M.
(2002). Heart failure in the young. Heart
88: 198-202
[Full Text]
Caforio, A. L.P., Mahon, N. J., Tona, F., McKenna, W. J.
(2002). Circulating cardiac autoantibodies in dilated cardiomyopathy and myocarditis: pathogenetic and clinical significance. Eur J Heart Fail
4: 411-417
[Abstract][Full Text]
Luo, H., Yanagawa, B., Zhang, J., Luo, Z., Zhang, M., Esfandiarei, M., Carthy, C., Wilson, J. E., Yang, D., McManus, B. M.
(2002). Coxsackievirus B3 Replication Is Reduced by Inhibition of the Extracellular Signal-Regulated Kinase (ERK) Signaling Pathway. J. Virol.
76: 3365-3373
[Abstract][Full Text]
Angelini, A, Crosato, M, Boffa, G M, Calabrese, F, Calzolari, V, Chioin, R, Daliento, L, Thiene, G
(2002). Active versus borderline myocarditis: clinicopathological correlates and prognostic implications. Heart
87: 210-215
[Abstract][Full Text]
Kaya, Z., Dohmen, K. M., Wang, Y., Schlichting, J., Afanasyeva, M., Leuschner, F., Rose, N. R.
(2002). Cutting Edge: A Critical Role for IL-10 in Induction of Nasal Tolerance in Experimental Autoimmune Myocarditis. J. Immunol.
168: 1552-1556
[Abstract][Full Text]
Afanasyeva, M., Wang, Y., Kaya, Z., Stafford, E. A., Dohmen, K. M., Sadighi Akha, A. A., Rose, N. R.
(2001). Interleukin-12 Receptor/STAT4 Signaling Is Required for the Development of Autoimmune Myocarditis in Mice by an Interferon-{gamma}-Independent Pathway. Circulation
104: 3145-3151
[Abstract][Full Text]
HAMILTON, J R L., HASAN, A.
(2001). Cardiopulmonary transplantation in children: a reason for optimism?. Heart
86: 607-608
[Full Text]
Kishimoto, C., Takada, H., Kawamata, H., Umatake, M., Ochiai, H.
(2001). Immunoglobulin Treatment Prevents Congestive Heart Failure in Murine Encephalomyocarditis Viral Myocarditis Associated with Reduction of Inflammatory Cytokines. J. Pharmacol. Exp. Ther.
299: 645-651
[Abstract][Full Text]
Mehta, N. J., Mehta, R. N., Khan, I. A.
(2001). Peripartum Cardiomyopathy: Clinical and Therapeutic Aspects. ANGIOLOGY
52: 759-762
[Abstract]
Duncan, B. W., Bohn, D. J., Atz, A. M., French, J. W., Laussen, P. C., Wessel, D. L.
(2001). Mechanical circulatory support for the treatment of children with acute fulminant myocarditis. J. Thorac. Cardiovasc. Surg.
122: 440-448
[Abstract][Full Text]
Liu, P. P., Mason, J. W.
(2001). Advances in the Understanding of Myocarditis. Circulation
104: 1076-1082
[Full Text]
Parrillo, J. E.
(2001). Inflammatory Cardiomyopathy (Myocarditis) : Which Patients Should Be Treated With Anti-Inflammatory Therapy?. Circulation
104: 4-6
[Full Text]
Wojnicz, R., Nowalany-Kozielska, E., Wojciechowska, C., Glanowska, G., Wilczewski, P., Niklewski, T., Zembala, M., Polonski, L., Rozek, M. M., Wodniecki, J.
(2001). Randomized, Placebo-Controlled Study for Immunosuppressive Treatment of Inflammatory Dilated Cardiomyopathy : Two-Year Follow-Up Results. Circulation
104: 39-45
[Abstract][Full Text]
Afanasyeva, M., Wang, Y., Kaya, Z., Park, S., Zilliox, M. J., Schofield, B. H., Hill, S. L., Rose, N. R.
(2001). Experimental Autoimmune Myocarditis in A/J mice Is an Interleukin-4-Dependent Disease with a Th2 Phenotype. Am. J. Pathol.
159: 193-203
[Abstract][Full Text]
Oomman, A., Ramachandran, P., Rao, P. V., Girinath, M. R.
(2001). Dor's endoaneurysmorrhaphy in severe heart failure due to giant cell myocarditis. Ann. Thorac. Surg.
71: 2036-2038
[Abstract][Full Text]
McNamara, D. M., Holubkov, R., Starling, R. C., Dec, G. W., Loh, E., Torre-Amione, G., Gass, A., Janosko, K., Tokarczyk, T., Kessler, P., Mann, D. L., Feldman, A. M.
(2001). Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy. Circulation
103: 2254-2259
[Abstract][Full Text]
Miyamoto, T., Matsumori, A., Hwang, M.-W., Nishio, R., Ito, H., Sasayama, S.
(2001). Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis. J Am Coll Cardiol
37: 1713-1718
[Abstract][Full Text]
D'Ambrosio, A, Patti, G, Manzoli, A, Sinagra, G, Di Lenarda, A, Silvestri, F, Di Sciascio, G
(2001). The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart
85: 499-504
[Full Text]
Sarda, L., Colin, P., Boccara, F., Daou, D., Lebtahi, R., Faraggi, M., Nguyen, C., Cohen, A., Slama, M. S., Steg, P. G., Le Guludec, D.
(2001). Myocarditis in patients with clinical presentation of myocardial infarction and normal coronary angiograms. J Am Coll Cardiol
37: 786-792
[Abstract][Full Text]
Acker, M. A.
(2001). Mechanical circulatory support for patients with acute-fulminant myocarditis. Ann. Thorac. Surg.
71
: S73-S76
[Abstract][Full Text]
Hare, J.M., Baughman, K.L.
(2001). Fulminant and acute lymphocytic myocarditis: the prognostic value of clinicopathological classification. Eur Heart J
22: 269-270